- A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. Fragasso, G., Palloshi, A., Puccetti, P., Silipigni, C., Rossodivita, A., Pala, M., Calori, G., Alfieri, O., Margonato, A. J. Am. Coll. Cardiol. (2006)